Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis, characterization and density functional theory of a novel dichloro(2-(1-anthracene-9-ylmethyl)-1H-1,2,3-triazole-5-yl) pyridine)Cu(II) and polymeric dichloro(2-(1-anthracene-9-ylmethyl)-1H-1,2,3 -triazole-5-yl)pyridine) Cd(II) complexes.

Journal of computer-aided molecular design·2025
Same author

A Structural Equation Modeling Approach for the Impact of Socioeconomic Status on Blood Pressure among Older Adults in India and the Role of Mediators - Evidence from the Longitudinal Aging Study of India - Wave 1.

Indian journal of public health·2025
Same author

Burden of female breast cancer in India: estimates of YLDs, YLLs, and DALYs at national and subnational levels based on the national cancer registry programme.

Breast cancer research and treatment·2024
Same author

Spin-glass behavior in a giant unit cell compound Tb₁₁₇Fe₅₂Ge₁₁₃.₈(₁).

Journal of physics. Condensed matter : an Institute of Physics journal·2014
Same author

Letters to the editor.

Orthopedics·2014
Same author

Shape selectivity by guest-driven restructuring of a porous material.

Angewandte Chemie (International ed. in English)·2014

Related Experiment Video

Updated: Jul 19, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Prostate cancer: serum and tissue markers.

G J Miller, M K Brawer, W A Sakr

    Reviews in Urology
    |September 21, 2006
    PubMed
    Summary

    This review covers advances in prostate cancer detection and prognosis. New assays, molecular markers, vitamin D, and insulin-like growth factor correlations are discussed, alongside updated radiologic staging.

    Area of Science:

    • Oncology
    • Urology
    • Biochemistry

    Background:

    • Prostate cancer detection, staging, and prognosis are critical for clinical management.
    • The digital rectal exam is being replaced by advanced diagnostic techniques.
    • Serum and tissue-based assays are increasingly important.

    Purpose of the Study:

    • To review recent advancements in prostate cancer diagnostics and prognostics.
    • To highlight novel serum and tissue-based assays.
    • To explore emerging biomarkers and risk factors.

    Main Methods:

    • Review of recent scientific literature and clinical studies.
    • Analysis of progress in prostate-specific antigen (PSA) assay development.
    • Examination of molecular markers, including DNA ploidy, nuclear morphometry, proliferation markers, and cell adhesion molecules.

    More Related Videos

    Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
    12:13

    Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

    Published on: November 19, 2019

    miRNA Expression Analyses in Prostate Cancer Clinical Tissues
    11:29

    miRNA Expression Analyses in Prostate Cancer Clinical Tissues

    Published on: September 8, 2015

    Related Experiment Videos

    Last Updated: Jul 19, 2026

    Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
    13:19

    Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

    Published on: November 2, 2013

    Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
    12:13

    Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

    Published on: November 19, 2019

    miRNA Expression Analyses in Prostate Cancer Clinical Tissues
    11:29

    miRNA Expression Analyses in Prostate Cancer Clinical Tissues

    Published on: September 8, 2015

  • Investigation of the relationship between vitamin D deficiency and prostate cancer.
  • Assessment of serum insulin-like growth factor (IGF) levels and prostate cancer risk.
  • Review of the latest radiologic staging techniques.
  • Main Results:

    • Development of prostate-specific antigen (PSA) assays with improved specificity.
    • Identification of various molecular markers for enhanced prostate cancer detection and characterization.
    • Evidence suggesting a link between vitamin D deficiency and prostate cancer development.
    • Potential correlation between serum insulin-like growth factor (IGF) levels and prostate cancer risk.
    • Significant advancements in radiologic staging methods for prostate cancer.

    Conclusions:

    • Novel diagnostic and prognostic tools are improving prostate cancer management.
    • Molecular markers and risk factor analysis offer new avenues for early detection and personalized treatment.
    • Continued research into biomarkers and imaging techniques is essential for optimizing patient outcomes.